囊性纤维化患者的妊娠
囊性纤维化(CF)是常染色体隐性单基因病,随着CFTR调节剂的应用和综合护理进步,美国成人CF患者数已超过儿童,中位预测预期寿命约61岁,近年CF女性妊娠数翻倍。妊娠会增加CF患者病率,计划妊娠者应接受母胎医学、遗传学及CF团队孕前咨询,不计划妊娠者应考虑避孕;服用CFTR调节剂时可鼓励母乳喂养,但需儿科医生监测婴儿可能的不良反应。
要点
- CFTR调节剂的应用可能促使近年CF女性妊娠数翻倍,妊娠会增加CF患者病率。
- 不计划妊娠的CF患者应考虑避孕;计划妊娠者应接受母胎医学、遗传学及CF团队孕前咨询。
- 服用CFTR调节剂时可鼓励母乳喂养,但儿科医生应监测婴儿可能的不良反应。
核心结论
- 随着CFTR调节剂的应用和综合护理进步,美国成人CF患者数已超过儿童,中位预测预期寿命约61岁,近年CF女性妊娠数翻倍。
- 妊娠会增加CF患者病率,计划妊娠者应接受母胎医学、遗传学及CF团队孕前咨询,不计划妊娠者应考虑避孕。
- 服用CFTR调节剂时可鼓励母乳喂养,但儿科医生应监测婴儿可能的不良反应。
- 单基因无创产前检测正在兴起,为筛查胎儿CF提供了新策略;新兴证据提示CFTR调节剂经胎盘转移可能延迟、预防或逆转胎儿CF的多项表现。
研究设计与样本
- 原文为综述,检索范围未报告。
主要发现
- 自2010年以来,CFTR调节剂这一新药物类别出现,使美国大多数CF患者健康结局改善。
- 这些新药物可能促使近年CF女性妊娠数翻倍。
- 新兴证据提示CFTR调节剂经胎盘转移可能延迟、预防或逆转胎儿CF的多项表现。
- 目前正在开展研究以探讨当代CF患者的妊娠与为人父母情况。
临床怎么用
- 不计划妊娠的CF患者应考虑避孕。
- 计划妊娠的CF患者应接受母胎医学、遗传学及专门CF团队的孕前咨询。
- 服用CFTR调节剂时可鼓励母乳喂养,但儿科医生应监测婴儿可能的不良反应。
- 单基因无创产前检测正在兴起,为筛查胎儿CF提供了新策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cystic fibrosis (CF) is an autosomal recessive, monogenic disorder that affects individuals of all races and ethnicities. It was historically viewed as a pediatric disease, but with comprehensive care and therapeutic advances, adults with CF now outnumber children living with CF in the United States, and the median predicted life expectancy is approximately 61 years. Since 2010, a new drug class called CF transmembrane conductance regulator (CFTR) modulators has emerged and led to improved health outcomes for most people with CF in the United States. These new medications have likely contributed to a doubling of pregnancies among women with CF in recent years. In the setting of increased fertility, people with CF should consider contraception when pregnancy is not desired. For people with CF who are seeking pregnancy, preconception consultation with expertise in maternal-fetal medicine and genetics and a dedicated CF team is important because of the increased morbidity among pregnant people with CF. Breastfeeding is possible and encouraged when taking CFTR modulators, although the pediatrician should monitor the infant for possible side effects given established transfer through breast milk. Single-gene noninvasive prenatal testing is emerging and offers a new strategy to screen for fetal CF, which is increasingly important with emerging evidence that transplacental transfer of CFTR modulators may delay, prevent, or reverse multiple CF manifestations for the fetus with CF. Research is ongoing to study pregnancy and parenthood in the modern era in people with CF.
引用
- Pineles BL, Jain R, Kazmerski TM, et al. Pregnancy in Patients With Cystic Fibrosis. Obstet Gynecol. 2025. PMID: 41037817. doi:10.1097/AOG.0000000000006084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。